Atlas Trials

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of NO-13065 in Healthy and Obese Adult Subjects

Clinical trial NCT04838639 · COMPLETED

Trial details

NCT number
NCT04838639
Sponsor
Otsuka Pharmaceutical Factory, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Obesity
Start date
2021-06-14
Primary completion
2022-03-31
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.